Investor Relations :: BioSig Technologies, Inc. (BSGM)

Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

First Name

Last Name

Email Address

Contact Type:

Sign me up for:

Press Releases

Annual & Qtr Reports

Current Reports

Insider Transactions

Proxy Information

All Filings

BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Expand RWA Tokenization for the Commodities Markets

July 7, 2025

View All News

Q1 2025

Quarter Ended Mar 31, 2025

PDF HTML

10-Q

ZIP XLS

XBRL

Latest Annual Report

View Annual Report

Symbol

Nasdaq: BSGM

Price

Change

Volume

52 week Low/High

Day Low/High

BioSig Technologies is a medical device company commercializing a proprietary technology platform designed to improve the $8 billion electrophysiology (EP) marketplace. By 2028, the EP market is expected to reach $16 billion, with an estimated 11.2% CAGR.

Download